"Optimization of the Formulation of Certain Buccal Delivery System"
REHAM ABDEL MAKSOUD ZAYED;
Abstract
Sildenafil (SILD) was approved by the U.S. Food and Drug Adminstration (FDA) for pulmonary arterial hypertension (PAH) treatment. Sublingual tablets (STs) of SILD was supposed to overcome SILD first-pass effect consequently enhancing oral bioavailability,
Other data
| Title | "Optimization of the Formulation of Certain Buccal Delivery System" | Other Titles | بعض الاعتبارات الصيدلية لتعظيم صياغة نظام ايتاء دوائى فموي معين" | Authors | REHAM ABDEL MAKSOUD ZAYED | Keywords | "Optimization of the Formulation of Certain Buccal Delivery System" | Issue Date | 2014 | Description | Sildenafil (SILD) was approved by the U.S. Food and Drug Adminstration (FDA) for pulmonary arterial hypertension (PAH) treatment. Sublingual tablets (STs) of SILD was supposed to overcome SILD first-pass effect consequently enhancing oral bioavailability, |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 124303G3694.pdf | 500.95 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.